Clinical trial

Lithium for the Treatment of Pediatric Mania

NCT00442039 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed

Key facts

NCT number NCT00442039
Title Lithium for the Treatment of Pediatric Mania
Official title Pediatric Pharmacokinetic and Tolerability Study of Lithium for the Treatment of Pediatric Mania Followed by an Open Label Long Term Safety Period, Discontinuation Phase, and Restabilization Period.
Lead sponsor Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH
Status Completed
Phase Phase 2
Study type Interventional
Conditions Bipolar I Disorder Without Psychotic Symptoms
Intervention type Drug
Interventions Lithium Carbonate, Placebo
Enrollment 61
Start date Dec 1, 2006
Primary completion Apr 1, 2009
Completion Sep 1, 2009
First posted Mar 1, 2007
Last update posted Feb 28, 2012
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies